Amanta Healthcar

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE084K01015
  • NSEID: AMANTA
  • BSEID: 544502
INR
101.00
-0.25 (-0.25%)
BSENSE

Dec 05

BSE+NSE Vol: 82.99 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Standalone Annual Results
Mar'25
Mar'24
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -2.01%

stock-summary

Standalone Net Profit

YoY Growth in year ended Mar 2025 is 189.26%

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 3.79%

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -16.91%

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has improved from Mar 2024

Compare Annual Results Of Amanta Healthcar With
Markets Mojo
Figures in Cr
Standalone Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
274.71
159.48
115.23
72.25%
Other Operating Income
0.00
0.00
0.00
Total Operating income
274.71
159.48
115.23
72.25%
Raw Material Cost
101.26
97.50
3.76
3.86%
Purchase of Finished goods
12.32
0.00
12.32
(Increase) / Decrease In Stocks
-19.53
1.04
-20.57
-1,977.88%
Employee Cost
36.34
16.35
19.99
122.26%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.00
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
84.64
37.37
47.27
126.49%
Total Expenditure (Excl Depreciation)
215.04
152.26
62.78
41.23%
Operating Profit (PBDIT) excl Other Income
59.67
7.22
52.45
726.45%
Other Income
1.39
0.69
0.70
101.45%
Operating Profit (PBDIT)
61.06
7.91
53.15
671.93%
Interest
27.95
5.19
22.76
438.54%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
33.11
2.72
30.39
1,117.28%
Depreciation
18.40
5.96
12.44
208.72%
Profit Before Tax
14.71
-3.24
17.95
554.01%
Tax
4.21
-1.95
6.16
315.90%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
10.50
-1.29
11.79
913.95%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
10.50
-1.29
11.79
913.95%
Equity Capital
2.83
9.71
-6.88
-70.85%
Face Value
10.00
10.00
0.00
Reserves
67.56
60.24
7.32
12.15%
Earnings per share (EPS)
37.10
-1.33
38.43
2,889.47%
Diluted Earnings per share
3.71
-1.33
5.04
378.95%
Operating Profit Margin (Excl OI)
21.72%
4.53%
0.00
17.19%
Gross Profit Margin
12.05%
1.71%
0.00
10.34%
PAT Margin
3.82%
-0.81%
0.00
4.63%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 274.71 Cr
in Mar 2025

Figures in Cr
Annual - Standalone Net Profit
Standalone Net Profit 10.50 Cr
in Mar 2025

Figures in Cr
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 59.67 Cr
in Mar 2025

Figures in Cr
Annual - Interest
Interest 27.95 Cr
in Mar 2025

Figures in Cr
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 21.72%
in Mar 2025

Figures in %